查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1785184

器官晶片市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、按產品、按材料類型、按應用、按最終用戶、按地區和競爭進行細分，2020 年至 2030 年預測

Organ-on-Chip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Offering, By Material Type, By Application, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球器官晶片市場規模達4.6757億美元，預計在預測期內將顯著成長，到2030年複合年成長率將達到25.61%。器官晶片是人體器官的精密人工複製品。這些尖端設備利用多通道3D微流控細胞培養技術，忠實模擬器官的功能、過程和生理反應。透過將晶片實驗室（LOC）與細胞生物學結合，研究人員成功創建了一種新型的體外多細胞人體模型，從而能夠在器官特定環境下分析人體生理學。

市場概覽
預測期 2026-2030
2024年市場規模 4.6757億美元
2030年市場規模 18.04億美元
2025-2030 年複合年成長率 25.61%
成長最快的領域 製藥和生物技術公司
最大的市場 北美洲

這些晶片具有設計精巧的微通道，可促進血液和氣流流動，從而能夠模擬各種器官，例如肺、腸、腦、肝和心臟。微晶片中植入活細胞，透過持續灌注促進組織和器官功能。器官晶片技術以其獨特的矽營養、組織工程和微流體技術相結合，有望徹底改變該領域。這些進步在解決藥物研發和疾病治療領域長期存在的挑戰方面擁有巨大的潛力，使其成為藥物研發研究的關鍵組成部分，並推動器官晶片產業的發展。

關鍵市場促進因素

電子晶片小型化需求日益成長

主要市場挑戰

器官晶片設備成本高引發擔憂

主要市場趨勢

市場發展日益

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球器官晶片市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（肝臟、心臟、肺、腎、其他）
    • 按產品（產品與服務）
    • 依材料類型（聚合物、PDMS、玻璃、矽、其他）
    • 按應用（生理模型開發、藥物發現、毒理學研究、分子生物學、其他）
    • 按最終用戶（製藥和生物技術公司、學術和研究機構、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美器官晶片市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲器官晶片市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太器官晶片市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美器官晶片市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲器官晶片市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球器官晶片市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Altis Biosystems
  • AxoSim Inc.
  • BiomimX SRL
  • Emulate Inc.
  • Hesperos
  • Allevi Inc.
  • InSphero AG
  • MIMETAS BV
  • Nortis Inc.
  • Hesperos, Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 7763

Global Organ-on-Chip Market was valued at USD 467.57 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 25.61% through 2030. Organs-on-chip are sophisticated artificial replicas of human organs. These cutting-edge devices utilize multichannel 3D microfluidic cell culture technology to faithfully mimic organ functions, processes, and physiological responses. By combining labs-on-chips (LOCs) with cell biology, researchers have successfully created a novel model of in vitro multicellular human beings, allowing for the analysis of human physiology within organ-specific environments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 467.57 Million
Market Size 2030USD 1804.00 Million
CAGR 2025-203025.61%
Fastest Growing SegmentPharmaceutical & Biotechnology Companies
Largest MarketNorth America

These chips feature intricately designed microchannels that facilitate blood and air flow, enabling the simulation of various organs such as the lung, intestine, brain, liver, and heart. The microchips are populated with live cells, fostering tissue and organ function through constant perfusion. Organ-on-chip technology, with its unique blend of silicone nourishment, tissue engineering, and microfluidics, has the potential to revolutionize the field. These advancements hold great promise in addressing longstanding challenges in drug discovery and disease treatment, making it a crucial component in drug development investigations and propelling the organ-on-chip industry forward.

Key Market Drivers

Growing Demand of Miniaturization of Electronic Chips

The growing prevalence for microchips in the field of medical devices is a direct result of remarkable technological advancements. These advancements have not only fueled the demand for such devices but also paved the way for significant improvements in their construction and maintenance. The process of miniaturization has played a key role in achieving these advancements, as it allows for the reduction of materials required to build and sustain the system.

Moreover, the utilization of microfluidic chips has revolutionized the development of miniaturized tissues, enabling the simulation of real tissue in organ-on-a-chip systems. By creating an in vitro environment at the microscopic scale, these microfluidic chips effectively mimic the function and structure of actual organs. This breakthrough technology holds tremendous promise in advancing our understanding of organ function and disease progression. The integration of microchips and microfluidic chips in medical devices marks a significant milestone in the field of healthcare. With continued research and innovation, we can expect even greater advancements in this fascinating area, ultimately leading to improved diagnostics, treatments, and overall patient care.

Key Market Challenges

Concerns Pertaining due to High Cost of Organ Chip Device

The high cost associated with the organ chip device, coupled with the fact that organ-on-chip (OOC) technology is still in its early stages, is projected to limit the expansion of the market. This is primarily due to the significant investment required for research and development, manufacturing, and commercialization of organ-on-chip devices. The complex nature of the technology, involving the integration of multiple organ models and microfluidic systems, adds to the manufacturing challenges and cost considerations.

Furthermore, certain countries have imposed restrictions on cosmetic testing on animals, which is likely to further hinder the growth of the global organ-on-chip market. In these countries, the government has prohibited the use of animals for testing cosmetics developed within their borders, reflecting a growing awareness and concern for animal welfare. This shift in regulatory policies has prompted the need for alternative testing methods, such as organ-on-chip technology, which can simulate the physiological conditions of human organs and provide more accurate and ethical results.

These factors collectively contribute to the complex landscape surrounding the adoption and market potential of organ-on-chip technology. While the technology holds great promise for revolutionizing drug discovery, toxicity testing, and personalized medicine, overcoming the barriers of cost, scale-up, and regulatory requirements remains crucial for its widespread adoption and market success. Continued advancements in technology, coupled with collaborative efforts between academia, industry, and regulatory bodies, will play a vital role in addressing these challenges and unlocking the full potential of organ-on-chip technology in improving healthcare outcomes.

Key Market Trends

Increasing Market Developments

The organ-on-chip market is witnessing significant growth largely driven by a series of strategic market developments such as product launches, collaborations, mergers, and acquisitions. Companies in this space are continuously innovating by launching new organ-on-chip devices that more accurately mimic human organs and their functions. These innovations not only improve the reliability and efficiency of the technology but also expand its applications across various fields including drug discovery, toxicology testing, and personalized medicine. As new products emerge, they attract a broader range of customers, which helps drive the overall market expansion.

Collaborations between biotech firms, pharmaceutical companies, and research institutions are playing a crucial role in accelerating the development and commercialization of organ-on-chip technologies. By combining expertise and resources, these partnerships help in speeding up research, validating new models, and entering new markets. Additionally, collaborations often enable sharing of high-cost resources and access to advanced technology platforms, which further promotes innovation and market penetration.

Mergers and acquisitions are also key drivers of growth in the organ-on-chip market. Larger companies are acquiring smaller startups that have developed innovative technologies, allowing them to quickly integrate new capabilities and expand their product portfolios. These consolidations provide companies with enhanced financial and technical resources, enabling more substantial investments in research and marketing. Moreover, such activities help strengthen competitive positioning and broaden the reach of organ-on-chip solutions.

Another important factor fueling market growth is increased funding from venture capital, government grants, and other investors. This influx of capital supports further innovation, clinical validation, and regulatory approval processes, all of which are critical to bringing advanced organ-on-chip products to market. In parallel, regulatory agencies are gradually recognizing the value of organ-on-chip platforms as alternatives to traditional animal testing, which has encouraged adoption by reducing barriers related to compliance and ethical concerns.

Key Market Players

  • Altis Biosystems
  • AxoSim Inc.
  • BiomimX SRL
  • Emulate Inc.
  • Hesperos
  • Allevi Inc.
  • InSphero AG
  • MIMETAS BV
  • Nortis Inc.
  • Hesperos, Inc.

Report Scope:

In this report, the Global Organ-on-Chip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ-on-Chip Market, By Type:

  • Liver
  • Heart
  • Lung
  • Kidney
  • Others

Organ-on-Chip Market, By Offering:

  • Products
  • Services

Organ-on-Chip Market, By Material Type:

  • Polymer
  • PDMS
  • Glass
  • Silicon
  • Others

Organ-on-Chip Market, By Application:

  • Physiological Model Development
  • Drug Discovery
  • Toxicological Research
  • Molecular Biology
  • Others

Organ-on-Chip Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Organ-on-Chip Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ-on-Chip Market.

Available Customizations:

Global Organ-on-Chip market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ-on-Chip Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Liver, Heart, Lung, Kidney, Others)
    • 5.2.2. By Offering (Products v/s Services)
    • 5.2.3. By Material Type (Polymer, PDMS, Glass, Silicon, Others)
    • 5.2.4. By Application (Physiological Model Development, Drug Discovery, Toxicological Research, Molecular Biology, Others)
    • 5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Market Map

6. North America Organ-on-Chip Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Offering
    • 6.2.3. By Material Type
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Organ-on-Chip Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Offering
        • 6.3.1.2.3. By Material Type
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Organ-on-Chip Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Offering
        • 6.3.2.2.3. By Material Type
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Organ-on-Chip Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Offering
        • 6.3.3.2.3. By Material Type
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Organ-on-Chip Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Offering
    • 7.2.3. By Material Type
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Organ-on-Chip Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Offering
        • 7.3.1.2.3. By Material Type
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. United Kingdom Organ-on-Chip Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Offering
        • 7.3.2.2.3. By Material Type
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Italy Organ-on-Chip Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Offering
        • 7.3.3.2.3. By Material Type
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. France Organ-on-Chip Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Offering
        • 7.3.4.2.3. By Material Type
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Organ-on-Chip Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Offering
        • 7.3.5.2.3. By Material Type
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Organ-on-Chip Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Offering
    • 8.2.3. By Material Type
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Organ-on-Chip Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Offering
        • 8.3.1.2.3. By Material Type
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Organ-on-Chip Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Offering
        • 8.3.2.2.3. By Material Type
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Organ-on-Chip Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Offering
        • 8.3.3.2.3. By Material Type
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Organ-on-Chip Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Offering
        • 8.3.4.2.3. By Material Type
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Organ-on-Chip Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Offering
        • 8.3.5.2.3. By Material Type
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Organ-on-Chip Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Offering
    • 9.2.3. By Material Type
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Organ-on-Chip Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Offering
        • 9.3.1.2.3. By Material Type
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Organ-on-Chip Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Offering
        • 9.3.2.2.3. By Material Type
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Organ-on-Chip Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Offering
        • 9.3.3.2.3. By Material Type
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Organ-on-Chip Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Offering
    • 10.2.3. By Material Type
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Organ-on-Chip Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Offering
        • 10.3.1.2.3. By Material Type
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Organ-on-Chip Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Offering
        • 10.3.2.2.3. By Material Type
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Organ-on-Chip Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Offering
        • 10.3.3.2.3. By Material Type
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Organ-on-Chip Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Altis Biosystems
    • 15.1.1. Business Overview
    • 15.1.2. Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. AxoSim Inc.
  • 15.3. BiomimX SRL
  • 15.4. Emulate Inc.
  • 15.5. Hesperos
  • 15.6. Allevi Inc.
  • 15.7. InSphero AG
  • 15.8. MIMETAS BV
  • 15.9. Nortis Inc.
  • 15.10. Hesperos, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer